It suggested that CEMIP activates CDC42/MAPK pathway-regulated EMT by enhancing the degradation of GRAF1, which is indispensable to CEMIP-mediated migration and invasion of CRC cells. The gene discussed is ARHGAP26; the disease is colorectal carcinoma.